Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142575 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-01-28 | 2021-05-20 | 132652 |
| ACT PRAMIPEXOLE | 1MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190722 |
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2020-06-04 | 2020-07-23 | 116699 |
| ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-11-18 | 2021-12-23 | 149588 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-07-08 | 2021-09-02 | 142172 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190719 |
| ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2020-05-29 | 2020-06-18 | 116138 |
| ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-01-15 | 2021-05-20 | 131673 |
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2020-12-03 | 2021-05-20 | 129530 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2020-12-03 | 2020-12-17 | 129520 |
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Actual shortage | 2024-11-08 | 2025-04-24 | 242361 |
| ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-06-10 | 2021-09-02 | 140660 |
| ACT PRAMIPEXOLE | 1MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195127 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195582 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2020-09-24 | 2020-11-19 | 125001 |
| ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2023-10-26 | 2024-01-11 | 208260 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Resolved | 2019-10-24 | 2020-05-14 | 97147 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Resolved | 2021-11-18 | 2025-04-29 | 149602 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-04-10 | 2020-10-22 | 111838 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Discontinued | 2025-03-20 | 2025-03-20 | 253186 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256091 |
| TEVA-FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256137 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |